fibronectin splice variant ED-A and on mechanical tension
. Several adhesion receptors belonging to the integrin family have been implicated in the regulation of the myofibroblast phenotype in vitro. The ␣4␤1 and ␣5␤1 integrins promote the myofibroblast phenotype by binding to fibronectin [16] . The ␣v␤1 integrin binds latent TGF-␤, which in concert with the ␣v␤6 integrin leads to TGF-␤ activation [17] and the development of the myofibroblast phenotype. The ␣v␤3 and ␣v␤5 integrins down-regulate ␣-SMA expression in myofibroblasts via binding to vitronectin [18] . In vitro studies have also suggested that the ␣1␤1 integrin is important for the up-regulation of ␣-SMA in cultured fibroblasts subjected to interstitial fluid flow [19] . Thus, adhesion and the nature of that adhesion seem to be important in the orchestration of events leading to acquisition of the myofibroblast phenotype.
In the present study, tissue analysis from different human pathologies suggested that the ␣1 integrin subunit, which associates exclusively with the ␤1 integrin subunit, forming the ␣1␤1 integrin heterodimer [20, 21] , a major collagen receptor, is important for the differentiation and maintenance of the myofibroblast phenotype, as defined by the expression of ␣-SMA. We tested this hypothesis using a genetic approach employing mice carrying a null mutation in the gene for the integrin ␣1 chain [22] .
Our data demonstrate a previously unrecognized importance of adhesion via the ␣1␤1 integrin in acquisition of the myofibroblast phenotype in vivo, which, in turn, is of central importance for the neoformation of vessels and supporting connective tissue structures.

Materials and methods
Surgical specimens
Full-thickness biopsies from human tissues were taken from: (i) colorectal adenocarcinoma (CC; n ϭ 4), (ii) adjacent normal colon (n ϭ 2), (iii) pannus formation from synevectomies due to rheumatoid arthritis (RA; n ϭ 3), (iv) normal synovia (n ϭ 3), (v) 7-day-old healing cutaneous wounds (n ϭ 3) and (vi) adjacent normal skin (n ϭ 2). The biopsies were snapfrozen. The human ethics committee at the Uppsala Academic Hospital, Sweden, approved the present study.
Antibodies and other reagents
The following antibodies were used: monoclonal antibody (mAb) F4/80, recognizing macrophages (Serotec, Raleigh, NC, USA); polyclonal antibody (pAb) anti-NG2, recognizing pericytes and smooth muscle cells [23] (Chemicon, Temecula, CA, USA); mAb anti-perlecan, recognizing heparan sulphate proteoglycan (Chemicon); FITC-labelled mAb anti-smooth muscle ␣-actin (␣-SMA), recognizing smooth muscle cells, myofibroblasts and pericytes [24] [25] [26] [26, 29, 30] (clone 225. 28 ; Sanbios, Uden, The Netherlands); mAb PAL-E, recognizing endothelial cells (Sanbios); mAb anti-procollagen type I C propeptide [31] (Pierce Chemical Corp., Rockford, IL, USA); mAb PDGFR-B2, recognizing activated PDGF ␤-receptors when used at a concentration of 1 g/ml [32] ; mAb anti-␣1 integrin subunit [20] 
Immunolabelling, imaging and numerical analysis
The 6-m tissue sections were fixed in 100% acetone and subjected to immunolabelling for light and immunofluorescence microscopy, as described previously [26, 35] 
In vivo Matrigel assay
The ␣1-deficient mice [22] and ␣1 Ϫ/Ϫ (n ϭ 4) BALB/c mice (backcrossed to BALB/c for at least nine generations), as previously described [37] .
Results
Immunofluorescence stainings, combined with computer-aided image analyses, were performed to characterize cell types with regard to the expression of particular antigens (markers) using a modification of a previously described methodology [26, 35] (Fig. 1) . In a first step, immunohistochemistry was used to determine whether specific cell-type markers defined by the use of antibodies were expressed in vessels or in the interstitium (Fig. 1, step 1 [26, 35] . Table 2 Spatial distribution of the markers used in this study in relation to the microvasculature based on the method used in Figure 1 Normal skin
Normal colon
Colorectal adenocarcinoma
Rheumatiod arthritis
Wound healing [26, 35] . Ϫ, less than 30% co-localization; ϩ, between 30% and 60% co-localization; ϩϩ, more than 60% co-localization.
EC (PAL-E) P (␣-SMA) EC (PAL-E) P (␣-SMA) EC (PAL-E) P (HMW) EC (PAL-E) P (␣-SMA) EC (PAL-E) P (␣-SMA)
␣-SMA Ϫ NA Ϫ NA Ϫ ϩϩ Ϫ NA Ϫ NA HMW-MAA Ϫ Ϫ Ϫ Ϫ Ϫ NA Ϫ ϩϩ Ϫ ϩϩ PDGF ␤-receptor Ϫ Ϫ Ϫ Ϫ Ϫ ϩϩ Ϫ ϩϩ Ϫ ϩϩ ␣ 1 ␤ 1 integrin ϩϩ ϩϩ ϩϩ ϩ ϩϩ ϩϩ ϩϩ ϩϩ ϩϩ ϩϩ ␣ 2 ␤ 1 integrin ϩϩ ϩ ϩϩ ϩ ϩϩ Ϫ Ϫ Ϫ Ϫ Ϫ ␣ 3 ␤ 1 integrin ϩϩ ϩ ϩϩ ϩ ϩϩ Ϫ ϩϩ Ϫ ϩϩ Ϫ ␣ 5 ␤ 1 integrin Ϫ ϩϩ ϩ Ϫ ϩϩ ϩϩ ϩϩ ϩϩ ϩϩ ϩϩ ␣ 6 ␤ 1 integrin ϩϩ Ϫ ϩϩ Ϫ ϩϩ Ϫ ϩϩ Ϫ ϩϩ Ϫ Normal␣-SMA Ϫ Ϫ NA Ϫ Ϫ HMW-MAA Ϫ Ϫ Ϫ NA NA PDGF ␣-receptor Ϫ Ϫ Ϫ ϩϩ ϩϩ ␣1␤1 integrin Ϫ Ϫ ϩϩ Ϫ Ϫ ␣2␤1 integrin ϩ ϩ ϩ Ϫ Ϫ ␣3␤1 integrin Ϫ Ϫ Ϫ Ϫ Ϫ ␣5␤1 integrin Ϫ Ϫ ϩϩ ϩϩ ϩϩ ␣6␤1 integrin Ϫ Ϫ Ϫ Ϫ Ϫ
Human tissues studied were normal skin, normal colon, tumour stroma formation in colorectal adenocarcinoma, pannus formation in rheumatoid arthritis and cutaneous healing wounds. Endothelial cells (EC) detected using PAL-E; pericytes (P) detected using ␣-SMA or HMW; interstitial fibroblast-like cells (I) detected using ␣-SMA or HMW. Stained sections were analysed by computer imaging processing, as detailed in Materials and methods. The recorded percentage values represent the spatial distribution of two mAb markers in relation to each other, measured in percentage of pixels that co-localize (1 pixel equals 0.9 m ϫ 0.9 m)
Expression of ␤ 1 integrin heterodimers in colorectal adenocarcinoma, cutaneous healing wounds and pannus formation in rheumatoid arthritis
The distribution of ␤1 integrin-associated ␣-subunits expressed in reactive tissues and their normal counterparts were studied focusing on the expression patterns in the microvascular compartment, including the endothelium and pericytes, and the non-vascular interstitial compartment, including fibroblasts. The ␣1, ␣2, ␣3 and ␣5 integrin subunits associate exclusively with the ␤1 integrin subunit, whereas the ␣6 integrin subunit is capable of associating with both ␤1 and ␤4 integrin subunits [20, 21] . The results are shown in Table 2 . For detection of blood vessels, the expression of PAL-E was used as an endothelial marker ( Fig In the tumour stroma of colorectal adenocarcinoma, endothelial cells expressed ␣1␤1, ␣2␤1, ␣3␤1, ␣5␤1 and ␣6 integrins ( Table 2) . Microvascular pericytes and interstitial fibroblasts had similar integrin expression profiles and mainly expressed ␣1␤1 and ␣5␤1 integrins ( Table 2 ). The latter two cell types both expressed ␣-SMA but could be distinguished by their spatial relationship to the endothelium and their differential expression of HMW-MAA and PDGF ␤-receptors (Table 2 and Fig. S1C-F) , as previously described [26] . Tumour acinar structures expressed ␣2␤1, ␣3␤1 and ␣6 integrins (data not shown). Table 2 ). In contrast to colorectal adenocarcinoma, interstitial fibroblasts, while expressing ␣5␤1 (Fig. S2E and F) , did not express the ␣1␤1 integrin (Fig. 2C and D and Fig. 3C-H) 
Fig. 2 Expression of phenotypical markers in colorectal adenocarcinoma (CC) and pannus formation in rheumatoid arthritis (RA). Immunohistochemical staining was performed in 6-m sections from CC (left column) and RA (right column) using mAbs to characterize expression profiles of phenotypical markers in relation to the vasculature for PAL-E (A, B), ␣1␤1 (C, D), ␣-SMA (E, F) and ASO2 (G and H). Expression profiles were similar in microvascular structures (arrow) in both CC and RA. However, expression profiles differed in interstitial structures (arrowhead) between the two conditions. In CC, the expression profiles in interstitial structures were positive for ␣1␤1 (C), ␣-SMA (E) and ASO2 (G). In contrast, the expression profiles in interstitial structures in RA were negative for ␣1␤1 (D) and ␣-SMA (F), but positive for ASO2 (H). Tumour acinar structures (*). The bar represents 200 m.
Endothelial cells in pannus formation in rheumatoid arthritis and in tissue situated immediately adjacent to maturing granulation tissue in 7-day-old cutaneous healing wounds expressed a similar integrin subunit profile compared with colorectal adenocarcinoma with the exception of ␣2␤1 integrin, which was not detected in the endothelium in cutaneous healing wounds or pannus formation (Table 2). Similar to what was observed in colorectal adenocarcinoma, microvascular pericytes in rheumatoid arthritis and cutaneous healing wounds expressed the ␣1␤1 and ␣5␤1 integrins (
Phenotypical characterization of connective tissue cells in tumour stroma, pannus formation in rheumatoid arthritis and cutaneous wound healing in human beings
The possibility that the ␣1␤1 integrin was linked to specific populations of non-endothelial connective tissue cells was investigated using the method outlined in Fig. 1 (Fig. 4A-D) . In colorectal adenocarcinoma, these procollagen type I C-propeptideexpressing cells also expressed ␣-SMA, thus identifying them as myofibroblasts (Fig. 4C) . In contrast, in rheumatoid arthritis and cutaneous healing wounds, procollagen type I C-propeptide did not co-localize with ␣-SMA (Fig. 4D) [22] . In the first set of experiments, Matrigels were inoculated subcutaneously in mice and harvested after 14 days [36] .
distribution between PAL-E (A, B), ␣1␤1 integrin (C, D) and ␣-SMA (E, F).
Co-localization of ␣1␤1 integrin and ␣-SMA is depicted in yellow (G, H).
Coexpression of ␣1␤1 integrin and ␣-SMA was seen in both CC (G) and RA (H). Vascular PAL-E-positive structures (arrow) in both CC (A) and RA (B) were positive for ␣1␤1 integrin and ␣-SMA (G, H). In CC, interstitial structures (arrowhead) expressed ␣1␤1 integrin and ␣-SMA (G). In contrast, interstitial structures (arrowhead) in RA were negative for ␣1␤1 integrin and ␣-SMA (H). Tumour acinar structures (*)
As previously described [36] , the wild-type mice displayed a substantial ingrowth of vessels into the Matrigel (Fig. 5A) . Newly formed vessels were, to a large extent, surrounded by NG2-and PDGF ␤-receptor-expressing pericytes invested in a perlecanpositive basement membrane (data not shown and [36] ). RFMexpressing fibroblasts were present in the Matrigel. These cells also expressed ␣-SMA. Because they were not associated with the microvasculature, they were defined as myofibroblasts (Fig. 5A and C) .
In the adjacent dermis, accumulations of connective tissue cells that expressed RFM and ␣-SMA were associated with the microvasculature, thus identifying them as pericytes. Some of these cells were also partly or completely dissociated from the vascular wall and accumulated in the perivascular interstitial space (Fig. 5E). Similar accumulations of perivascular cells were observed in the dermis adjacent to Matrigels implanted in ␣1-deficient
animals, although to a lesser extent. These cells were positive for RFM but negative for ␣-SMA (Fig. 5D) 
mice. Optical sections were obtained using confocal laser microscopy and viewed as composites (A-F). Co-localization is depicted in yellow. (A, B) Note ingrowth into the Matrigel (M) of CD31-positive microvessels (arrowhead) surrounded by ␣-SMA-positive myofibroblasts (arrow) in wild-type (A) but not in ␣1 Ϫ/Ϫ mice (B). (C, D) Note ingrowth into the Matrigel (M) of myofibroblasts positive for both RFM and ␣-SMA in wild-type (C) mice in contrast to Matrigels in ␣1 Ϫ/Ϫ (D) mice that contained RFMpositive fibroblasts that were negative for ␣-SMA (arrow). (E, F) Note RFMexpressing cells that are juxtapositioned to, partially detached (arrow) from, the CD31-positive endothelium (arrowhead) that have accumulated in the perivascular space in dermis (*) adjacent to the Matrigel (M) in wild-type (E) mice and, albeit to a lesser degree, also in ␣1 Ϫ/Ϫ (F) mice. (G, H) Note well-developed cellular connective tissue septa (arrow) in Matrigels in wild-type (G) but not in ␣1 Ϫ/Ϫ (H) mice, where only isolated accumulations of cells (arrow) were observed. Matrigel/dermal interface (dotted line). The bar represents 40 m.
of angiogenesis in an ␣1 integrin-deficient environment ( Fig. 5A  and B) . Furthermore, the cellular content of Matrigels inoculated in ␣1-deficient mice was positive for RFM but not for ␣-SMA (Fig. 5D ) (Fig. 7A) . In these animals, no formation of connective tissue septa in the Matrigel was observed compared with wild-type animals, where both vessels and myofibroblasts were primarily concentrated to networks of connective tissue septa extending from the normal adjacent tissue (Fig. 5G and H) . However, in ␣1-deficient mice, the Matrigels were not acellular as both macrophages (data not shown) and RFM-expressing fibroblasts were present (Fig. 5D) . A 53% reduction in area covered by RFM-positive pixels (Fig. 7A) and a 97% reduction in the area covered by ␣-SMApositive pixels were observed in ␣1-deficient mice (Fig. 7A) Fig. 6I and J) . In contrast to ␣1-deficient mice, these perivascular cells also expressed ␣-SMA (Fig. 6I and J) in wild-type mice, thus identifying them as myofibroblasts. In ␣1-deficient mice, the expression of ␣-SMA was largely confined to the vascular space (Fig. 6J) . The fine fibrillar/reticular cellular extensions creating a meshwork interconnecting the microvasculature in tumours in wild-type mice ( Fig. 6G and I) were not observed in tumours in ␣1-deficient mice (Fig. 6H and J) . Furthermore, the overall cellular density was lower in tumours in wild-type mice compared with ␣1-deficient mice (Fig. 6K and L) . A quantification made for the markers above (Fig. 7B) [19] . The evidence in the present study suggests that the ␣1␤1 integrins are also important for the development of myofibroblasts in vivo.
. In addition, in both conditions, F4/80-expressing macrophages had infiltrated the Matrigel (data not shown). Quantification of blood vessel density showed a 90% reduction in the area covered by CD31-positive pixels in the Matrigels implanted in deficient animals compared with wild-type animals
In the present study of human reactive tissues, interstitial fibroblasts differed in their marker expression profiles in tumour stroma compared with pannus formation and wound healing. One explanation for this might be tissue specificity or that these cells are derived from different populations of precursor cells [14] . Heterogeneity of fibrogenic cells not only between tissues but also within the same tissue has previously been shown [38] [39] [40] . For instance, in the liver, phenotypically divergent fibrogenic cells are derived from different populations of precursor cells [41, 42] . Although there are important pathophysiological similarities between stroma formation in solid tumours and wound healing, the composition of the matrix is not identical [4] . Thus, one possibility for this divergence is the differences in cytokine expression and composition of the ECM components of the microenvironment. It has been shown that spatially distinct connective tissue cell populations respond differently to different cytokines [15] . For instance, a distinct population of periportal cells in liver undergoes a PDGF-BB-dependent conversion to a pro-fibrotic phenotype distinct from myofibroblasts in septal fibrosis [43] . The current observations made in human reactive tissues suggest, and are supported by the experimental models used in this study, that interactions between the ECM and connective tissue cells modify the phenotype of the cells, and that this interaction uses the ␣1␤1 integrin as a conduit for this purpose.
The cellular origins of fibroblasts/myofibroblasts are unclear. We have previously shown that microvascular pericytes become activated in tumour stroma, pannus in rheumatoid synovitis and healing wounds [26, 44, 45] . Upon activation, these pericytes express several markers including PDGF ␤-receptors, HMW-MAA and ␣-SMA. Thus, the activation of microvascular pericytes [36] . In similar models, using Matrigel plugs containing VEGF-A-transfected cells and syngeneic tumour models in mice, inhibition of ␣1␤1 and/or ␣2␤1 integrins perturbed ingrowth of blood vessels and tumour growth [52] [53] [54] [37, 54] . The differences between the Matrigel and syngeneic colorectal adenocarcinoma models may partly be due to the more complex array of ECM and cytokines within the tumour microenvironment. Furthermore, in the tumour model, co-option and expansion of already existing vasculature may occur, limiting the need for the neoformation of vessels and surrounding stroma [55] .
extirpated, sectioned and triple stained with regard to the markers for the endothelial cells (CD31), pericytes/smooth muscle cells and myofibroblasts (␣-SMA) and pericytes and fibroblasts (RFM
The differences in connective tissue cell phenotype in the Matrigels from ␣1-deficient mice compared with wild-type mice may be due to the differences in the inflammatory response. Monocytes/macrophages express the ␣1␤1 integrin. Therefore one possibility is that the differences in fibroblast phenotype in the ␣1-deficient mice is due to the lack of inflammatory cells, which, in turn, produce cytokines that influence the fibroblast phenotype [56, 57] [60, 61] . Discordance between pharmacological and genetic studies in mice adds to the complexity of interpreting the potential role of integrins in vivo [60] . The latter may be partially explained by transdominant inhibition, where occupation of one type of integrin leads to inhibition of the function of other specific integrins in the same cell [62] [22, 54] . Evidence supporting discrepancies in the role of the fibroblast/myofibroblast lineage in embryonic versus adult reactive tissues does exist [50, 51] . It has been shown that the ␣1␤1 integrin plays a role in reactive tissues such as the stromal response in solid tumours and the neoformation of blood vessels with a supporting connective tissue [52] [53] [54] . One possibility is that embryonic tissue morphogenesis, compared with repair processes in the adult where damaged tissue is replaced, differs in cell-matrix interactions [7] . Furthermore, it has been shown that myofibroblasts are not a prominent feature in foetal tissue repair, a process that results in minimal scarring [7, 15] . Our results support the notion that, although the ␣1␤1 integrin is non-essential during embryogenesis [22, 54] 
